FRAME staff and Trustees, and post-graduates from the FRAME Alternatives Laboratory took part in the ninth World Congress on Alternatives and Animal Use in the Life Sciences, in Prague, Czech Republic.

Two posters featuring FRAME research were displayed. One was by FRAME Scientific Officer Kevin Coll, on the rise in use of genetically modified (GM) mice in current research and their relevance as a model for human diseases. The other was by FAL PhD candidate Richard Maclennan, on development of a dynamic 3D liver model for chronic toxicity testing. (Click here for more details)

Attendees at the event were given a poster of FRAME’s alternatives timeline in their delegate packs. The poster was designed to give key dates and information about milestones in the development of alternatives to the use of animals in laboratories. Although it is a metre long, it is only 10cm high, so it is suitable for display on laboratory or classroom walls without using too much space.

The theme of this year’s World Congress was “Humane Science in the 21st Century”. A statement issued by Congress Co-chairs Dagmar Jírová and Horst Spielmann said: “ The world congress provides an exceptional forum to underline the importance of both the ethical issues of animal experimentation and the approach to the life sciences in the 21st century.”

Among the keynote speakers at the Congress were Michel Goldman, Executive Director of Innovative Medicines Initiative (IMI), Brussels, Belgium, who also delivered the FRAME Annual Lecture two years ago, and Uwe Marx, Founder and Chief Scientific Officer of TissUse, Berlin, Germany, one of the winners of the FRAME Dorothy Hegarty Award 2012.


Photo l-r: Kevin Coll, Richard Maclennan, Trustee Andrew Bennett, Chair of Trustees Anna Cadogan, ATLA editor Susan Trigwell.